Xencor (XNCR) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

XNCR Stock Forecast


Xencor stock forecast is as follows: an average price target of $42.60 (represents a 97.96% upside from XNCR’s last price of $21.52) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.

XNCR Price Target


The average price target for Xencor (XNCR) is $42.60 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $58.00 to $31.00. This represents a potential 97.96% upside from XNCR's last price of $21.52.

XNCR Analyst Ratings


Buy

According to 6 Wall Street analysts, Xencor's rating consensus is 'Buy'. The analyst rating breakdown for XNCR stock is 1 'Strong Buy' (16.67%), 5 'Buy' (83.33%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Xencor Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 14, 2024Etzer DaroutBMO Capital$32.00$20.8953.15%48.70%
Jun 14, 2024Gregory RenzaRBC Capital$31.00$20.9947.69%44.05%
Apr 16, 2024Kaveri PohlmanBTIG$38.00$20.1188.96%76.58%
Oct 04, 2021Charles ZhuGuggenheim$54.00$35.5252.03%150.93%
May 05, 2021Dane LeoneRaymond James$58.00$40.7642.30%169.52%
Row per page
Go to

The latest Xencor stock forecast, released on Jun 14, 2024 by Etzer Darout from BMO Capital, set a price target of $32.00, which represents a 53.15% increase from the stock price at the time of the forecast ($20.89), and a 48.70% increase from XNCR last price ($21.52).

Xencor Price Target by Period


1M3M12M
# Anlaysts--3
Avg Price Target--$33.67
Last Closing Price$21.52$21.52$21.52
Upside/Downside-100.00%-100.00%56.46%

In the current month, the average price target of Xencor stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Xencor's last price of $21.52. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Sep 26, 2024RBC CapitalOutperformOutperformHold
Jun 14, 2024BMO CapitalOutperformOutperformHold
Jun 14, 2024RBC CapitalOutperformOutperformHold
May 10, 2024WedbushBuyBuyHold
Apr 16, 2024WedbushBuyBuyHold
Apr 16, 2024BTIGBuyBuyHold
Feb 28, 2024WedbushBuyBuyHold
Feb 28, 2024RBC CapitalUnderperformUnderperformHold
Dec 06, 2022Cowen & Co.-OutperformInitialise
Oct 13, 2022Raymond James-Strong BuyUpgrade
Row per page
Go to

Xencor's last stock rating was published by RBC Capital on Sep 26, 2024. The company gave XNCR a "Outperform" rating, the same as its previous rate.

Xencor Financial Forecast


Xencor Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue------------$44.69M$59.16M$45.52M$18.96M$21.61M$27.30M$30.18M$85.50M$154.01M$19.68M$67.45M$33.97M$41.85M$35.37M$13.09M$32.38M$3.52M$21.76M
Avg Forecast$20.57M$20.57M$20.57M$20.57M$18.93M$17.55M$15.97M$14.67M$24.45M$14.59M$20.00M$23.07M$77.63M$30.01M$26.25M$28.72M$20.07M$21.05M$34.01M$26.14M$76.29M$20.74M$18.51M$16.01M$30.51M$36.01M$11.71M$14.64M$14.31M$6.72M
High Forecast$20.57M$20.57M$20.57M$20.57M$18.93M$17.55M$15.97M$14.67M$24.45M$32.05M$20.56M$23.07M$121.33M$30.01M$26.25M$28.72M$20.07M$21.05M$34.01M$26.14M$76.29M$20.74M$18.51M$16.01M$30.51M$36.01M$11.71M$14.64M$14.31M$6.72M
Low Forecast$20.57M$20.57M$20.57M$20.57M$18.93M$17.55M$15.97M$14.67M$24.45M$1.38M$19.44M$23.07M$11.03M$30.01M$26.25M$28.72M$20.07M$21.05M$34.01M$26.14M$76.29M$20.74M$18.51M$16.01M$30.51M$36.01M$11.71M$14.64M$14.31M$6.72M
# Analysts334545223734845443435454547655
Surprise %------------0.58%1.97%1.73%0.66%1.08%1.30%0.89%3.27%2.02%0.95%3.64%2.12%1.37%0.98%1.12%2.21%0.25%3.24%

Xencor's average Quarter revenue forecast for Mar 24 based on 4 analysts is $23.07M, with a low forecast of $23.07M, and a high forecast of $23.07M. XNCR's average Quarter revenue forecast represents a -48.37% decrease compared to the company's last Quarter revenue of $44.69M (Dec 23).

Xencor EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts334545223734845443435454547655
EBITDA------------$-33.47M$-18.27M$-26.00M$-59.37M$-42.59M$-41.41M$-19.23M$32.07M$75.17M$-38.20M$54.00M$-849.00K$1.52M$-11.10M$-33.58M$-6.70M$-25.98M$-9.50M
Avg Forecast$-6.73M$-6.73M$-6.73M$-6.73M$-6.19M$-5.74M$-5.22M$-4.80M$-7.99M$-4.77M$-6.54M$-7.54M$-25.39M$-9.81M$-8.59M$-9.39M$-6.56M$-6.88M$-11.12M$-8.55M$-24.95M$-6.78M$-6.05M$-1.48M$-9.98M$-11.77M$-3.83M$-9.84M$-4.68M$-2.20M
High Forecast$-6.73M$-6.73M$-6.73M$-6.73M$-6.19M$-5.74M$-5.22M$-4.80M$-7.99M$-450.06K$-6.36M$-7.54M$-3.61M$-9.81M$-8.59M$-9.39M$-6.56M$-6.88M$-11.12M$-8.55M$-24.95M$-6.78M$-6.05M$-1.19M$-9.98M$-11.77M$-3.83M$-7.87M$-4.68M$-2.20M
Low Forecast$-6.73M$-6.73M$-6.73M$-6.73M$-6.19M$-5.74M$-5.22M$-4.80M$-7.99M$-10.48M$-6.72M$-7.55M$-39.67M$-9.81M$-8.59M$-9.39M$-6.56M$-6.88M$-11.12M$-8.55M$-24.95M$-6.78M$-6.05M$-1.78M$-9.98M$-11.77M$-3.83M$-11.81M$-4.68M$-2.20M
Surprise %------------1.32%1.86%3.03%6.32%6.49%6.02%1.73%-3.75%-3.01%5.63%-8.92%0.57%-0.15%0.94%8.77%0.68%5.55%4.32%

4 analysts predict XNCR's average Quarter EBITDA for Jun 22 to be $-11.12M, with a high of $-11.12M and a low of $-11.12M. This is -134.67% lower than Xencor's previous annual EBITDA (Mar 22) of $32.07M.

Xencor Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts334545223734845443435454547655
Net Income------------$-19.10M$-24.27M$-21.95M$-59.92M$-12.04M$-32.76M$-39.95M$23.59M$73.06M$-40.19M$52.25M$-2.49M$-13.69K$-12.55M$-35.02M$-8.07M$-26.91M$-10.22M
Avg Forecast$-54.89M$-54.89M$-55.51M$-55.51M$-61.55M$-59.24M$-59.86M$-58.90M$-48.73M$-60.54M$-51.24M$90.05M$-6.54M$-44.80M$-49.16M$71.18M$866.88M$-41.70M$-30.46M$56.27M$1.73M$-38.92M$-36.19M$-4.34M$-23.36M$-13.79M$-31.64M$-11.86M$-25.35M$-33.64M
High Forecast$-54.89M$-54.89M$-55.51M$-55.51M$-61.55M$-59.24M$-59.86M$-58.90M$-48.73M$-52.51M$-51.24M$108.06M$24.52M$-44.80M$-49.16M$85.42M$1.04B$-41.70M$-30.46M$67.53M$1.73M$-38.92M$-36.19M$-3.47M$-23.36M$-13.79M$-31.64M$-9.48M$-25.35M$-33.64M
Low Forecast$-54.89M$-54.89M$-55.51M$-55.51M$-61.55M$-59.24M$-59.86M$-58.90M$-48.73M$-66.72M$-51.24M$72.04M$-34.33M$-44.80M$-49.16M$56.95M$693.50M$-41.70M$-30.46M$45.02M$1.73M$-38.92M$-36.19M$-5.21M$-23.36M$-13.79M$-31.64M$-14.23M$-25.35M$-33.64M
Surprise %------------2.92%0.54%0.45%-0.84%-0.01%0.79%1.31%0.42%42.29%1.03%-1.44%0.57%0.00%0.91%1.11%0.68%1.06%0.30%

Xencor's average Quarter net income forecast for Jun 22 is $-30.46M, with a range of $-30.46M to $-30.46M. XNCR's average Quarter net income forecast represents a -229.11% decrease compared to the company's last Quarter net income of $23.59M (Mar 22).

Xencor SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts334545223734845443435454547655
SG&A------------$15.27M$12.49M$11.46M$13.95M$12.75M$12.37M$11.09M$11.27M$11.38M$10.37M$8.86M$8.23M$7.60M$7.64M$7.23M$7.22M$6.75M$6.27M
Avg Forecast$4.42M$4.42M$4.42M$4.42M$4.07M$3.78M$3.43M$3.16M$5.26M$3.14M$4.30M$4.96M$16.70M$6.45M$5.65M$6.18M$4.32M$4.53M$7.32M$5.62M$16.41M$4.46M$3.98M$14.36M$6.56M$7.74M$2.52M$10.60M$3.08M$1.45M
High Forecast$4.42M$4.42M$4.42M$4.42M$4.07M$3.78M$3.43M$3.16M$5.26M$6.89M$4.42M$4.96M$26.10M$6.45M$5.65M$6.18M$4.32M$4.53M$7.32M$5.62M$16.41M$4.46M$3.98M$17.24M$6.56M$7.74M$2.52M$12.72M$3.08M$1.45M
Low Forecast$4.42M$4.42M$4.42M$4.42M$4.07M$3.78M$3.43M$3.16M$5.26M$296.04K$4.18M$4.96M$2.37M$6.45M$5.65M$6.18M$4.32M$4.53M$7.32M$5.62M$16.41M$4.46M$3.98M$11.49M$6.56M$7.74M$2.52M$8.48M$3.08M$1.45M
Surprise %------------0.91%1.94%2.03%2.26%2.95%2.73%1.52%2.00%0.69%2.33%2.23%0.57%1.16%0.99%2.87%0.68%2.19%4.33%

Xencor's average Quarter SG&A projection for Mar 24 is $4.96M, based on 4 Wall Street analysts, with a range of $4.96M to $4.96M. The forecast indicates a -67.50% fall compared to XNCR last annual SG&A of $15.27M (Dec 23).

Xencor EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts334545223734845443435454547655
EPS------------$-0.31$-0.40$-0.37$-1.00$-0.20$-0.55$-0.67$0.40$1.25$-0.69$0.90$-0.04$-0.00$-0.22$-0.61$-0.14$-0.47$-0.18
Avg Forecast$-0.89$-0.89$-0.90$-0.90$-1.00$-0.96$-0.97$-0.96$-0.79$-0.98$-0.83$-0.83$-0.11$-0.73$-0.80$-0.66$-0.79$-0.68$-0.49$-0.55$0.03$-0.63$-0.59$-0.67$-0.38$-0.22$-0.51$-0.38$-0.41$-0.55
High Forecast$-0.89$-0.89$-0.90$-0.90$-1.00$-0.96$-0.97$-0.96$-0.79$-0.85$-0.83$-0.83$0.40$-0.73$-0.80$-0.66$-0.79$-0.68$-0.49$-0.55$0.03$-0.63$-0.59$-0.67$-0.38$-0.22$-0.51$-0.38$-0.41$-0.55
Low Forecast$-0.89$-0.89$-0.90$-0.90$-1.00$-0.96$-0.97$-0.96$-0.79$-1.08$-0.83$-0.83$-0.56$-0.73$-0.80$-0.66$-0.79$-0.68$-0.49$-0.55$0.03$-0.63$-0.59$-0.67$-0.38$-0.22$-0.51$-0.38$-0.41$-0.55
Surprise %------------2.92%0.55%0.46%1.51%0.25%0.81%1.36%-0.73%44.63%1.09%-1.53%0.06%0.00%0.98%1.19%0.37%1.14%0.33%

According to 4 Wall Street analysts, Xencor's projected average Quarter EPS for Jun 22 is $-0.49, with a low estimate of $-0.49 and a high estimate of $-0.49. This represents a -223.48% decrease compared to XNCR previous annual EPS of $0.40 (Mar 22).

Xencor Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
STROSutro Biopharma$3.69$11.14201.90%Buy
FIXXQ32 Bio$0.93$2.70190.32%Buy
LRMRLarimar Therapeutics$7.57$20.33168.56%Buy
ANABAnaptysBio$19.94$52.33162.44%Buy
ERASErasca$2.87$7.00143.90%Buy
MLYSMineralys Therapeutics$13.50$30.00122.22%Buy
REPLReplimune Group$12.02$24.20101.33%Buy
XNCRXencor$21.52$42.6097.96%Buy
SNDXSyndax Pharmaceuticals$18.94$36.1190.65%Buy
KROSKeros Therapeutics$59.95$102.0070.14%Buy
VRDNViridian Therapeutics$22.84$37.8365.63%Buy
IDYAIDEAYA Biosciences$30.00$48.3661.20%Buy
MGTXMeiraGTx$5.96$9.0051.01%Buy
MRUSMerus$51.23$77.1350.56%Buy
KURAKura Oncology$17.81$26.0045.99%Buy
EWTXEdgewise Therapeutics$34.48$45.0030.51%Buy
DICEDICE Therapeutics$47.55$60.0026.18%Buy
NUVLNuvalent$89.53$107.8320.44%Buy
PCVXVaxcyte$106.49$124.1416.57%Buy
PTGXProtagonist Therapeutics$46.76$50.006.93%Buy
ACLXArcellx$86.44$71.57-17.20%Buy
CERECerevel Therapeutics$44.96$33.50-25.49%Buy

XNCR Forecast FAQ


Yes, according to 6 Wall Street analysts, Xencor (XNCR) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 5 'Buy' recommendations, accounting for 100.00% of XNCR's total ratings.

Xencor (XNCR) average price target is $42.6 with a range of $31 to $58, implying a 97.96% from its last price of $21.52. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for XNCR stock, the company can go up by 97.96% (from the last price of $21.52 to the average price target of $42.6), up by 169.52% based on the highest stock price target, and up by 44.05% based on the lowest stock price target.

XNCR's average twelve months analyst stock price target of $42.6 supports the claim that Xencor can reach $30 in the near future.

Xencor's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $67.11M (high $67.11M, low $67.11M), average EBITDA is $-21.946M (high $-21.946M, low $-21.946M), average net income is $-240M (high $-240M, low $-240M), average SG&A $14.44M (high $14.44M, low $14.44M), and average EPS is $-3.884 (high $-3.884, low $-3.884). XNCR's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $82.28M (high $82.28M, low $82.28M), average EBITDA is $-26.906M (high $-26.906M, low $-26.906M), average net income is $-221M (high $-221M, low $-221M), average SG&A $17.7M (high $17.7M, low $17.7M), and average EPS is $-3.58 (high $-3.58, low $-3.58).

Based on Xencor's last annual report (Dec 2023), the company's revenue was $168.34M, beating the average analysts forecast of $162.62M by 3.52%. Apple's EBITDA was $-138M, beating the average prediction of $-53.176M by 160.41%. The company's net income was $-126M, beating the average estimation of $-29.317M by 330.07%. Apple's SG&A was $53.38M, beating the average forecast of $34.98M by 52.61%. Lastly, the company's EPS was $-2.08, missing the average prediction of $-2.293 by -9.27%. In terms of the last quarterly report (Dec 2023), Xencor's revenue was $44.69M, missing the average analysts' forecast of $77.63M by -42.44%. The company's EBITDA was $-33.466M, beating the average prediction of $-25.386M by 31.83%. Xencor's net income was $-19.1M, beating the average estimation of $-6.54M by 192.07%. The company's SG&A was $15.27M, missing the average forecast of $16.7M by -8.54%. Lastly, the company's EPS was $-0.31, beating the average prediction of $-0.106 by 192.37%